Global Dermal Substitutes Market Research Report 2021

1 Dermal Substitutes Market Overview

• 1.1 Product Overview and Scope of Dermal Substitutes
• 1.2 Dermal Substitutes Segment by Type
  • 1.2.1 Global Dermal Substitutes Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Synthetic
  • 1.2.3 Biosynthetic
  • 1.2.4 Biological
• 1.3 Dermal Substitutes Segment by Application
  • 1.3.1 Dermal Substitutes Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospitals
  • 1.3.3 Wound Care Centers
  • 1.3.4 Others
• 1.4 Global Dermal Substitutes Market Size Estimates and Forecasts
  • 1.4.1 Global Dermal Substitutes Revenue 2016-2027
  • 1.4.2 Global Dermal Substitutes Sales 2016-2027
  • 1.4.3 Dermal Substitutes Market Size by Region: 2016 Versus 2021 Versus 2027

2 Dermal Substitutes Market Competition by Manufacturers

• 2.1 Global Dermal Substitutes Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Dermal Substitutes Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Dermal Substitutes Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Dermal Substitutes Manufacturing Sites, Area Served, Product Type
• 2.5 Dermal Substitutes Market Competitive Situation and Trends
  • 2.5.1 Dermal Substitutes Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Dermal Substitutes Players Market Share by Revenue
  • 2.5.3 Global Dermal Substitutes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Dermal Substitutes Retrospective Market Scenario by Region

• 3.1 Global Dermal Substitutes Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Dermal Substitutes Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Dermal Substitutes Market Facts & Figures by Country
  • 3.3.1 North America Dermal Substitutes Sales by Country
  • 3.3.2 North America Dermal Substitutes Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Dermal Substitutes Market Facts & Figures by Country
  • 3.4.1 Europe Dermal Substitutes Sales by Country
  • 3.4.2 Europe Dermal Substitutes Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Dermal Substitutes Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Dermal Substitutes Sales by Region
  • 3.5.2 Asia Pacific Dermal Substitutes Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Dermal Substitutes Market Facts & Figures by Country
  • 3.6.1 Latin America Dermal Substitutes Sales by Country
  • 3.6.2 Latin America Dermal Substitutes Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Dermal Substitutes Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Dermal Substitutes Sales by Country
  • 3.7.2 Middle East and Africa Dermal Substitutes Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Dermal Substitutes Historic Market Analysis by Type

• 4.1 Global Dermal Substitutes Sales Market Share by Type (2016-2021)
• 4.2 Global Dermal Substitutes Revenue Market Share by Type (2016-2021)
• 4.3 Global Dermal Substitutes Price by Type (2016-2021)

5 Global Dermal Substitutes Historic Market Analysis by Application

• 5.1 Global Dermal Substitutes Sales Market Share by Application (2016-2021)
• 5.2 Global Dermal Substitutes Revenue Market Share by Application (2016-2021)
• 5.3 Global Dermal Substitutes Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Integra Life Sciences
  • 6.1.1 Integra Life Sciences Corporation Information
  • 6.1.2 Integra Life Sciences Description and Business Overview
  • 6.1.3 Integra Life Sciences Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Integra Life Sciences Product Portfolio
  • 6.1.5 Integra Life Sciences Recent Developments/Updates
• 6.2 Smith and Nephew
  • 6.2.1 Smith and Nephew Corporation Information
  • 6.2.2 Smith and Nephew Description and Business Overview
  • 6.2.3 Smith and Nephew Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Smith and Nephew Product Portfolio
  • 6.2.5 Smith and Nephew Recent Developments/Updates
• 6.3 Organogenesis
  • 6.3.1 Organogenesis Corporation Information
  • 6.3.2 Organogenesis Description and Business Overview
  • 6.3.3 Organogenesis Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Organogenesis Product Portfolio
  • 6.3.5 Organogenesis Recent Developments/Updates
• 6.4 Yantai Zhenghai Bio-tech
  • 6.4.1 Yantai Zhenghai Bio-tech Corporation Information
  • 6.4.2 Yantai Zhenghai Bio-tech Description and Business Overview
  • 6.4.3 Yantai Zhenghai Bio-tech Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Yantai Zhenghai Bio-tech Product Portfolio
  • 6.4.5 Yantai Zhenghai Bio-tech Recent Developments/Updates
• 6.5 Guanhao Biotech
  • 6.5.1 Guanhao Biotech Corporation Information
  • 6.5.2 Guanhao Biotech Description and Business Overview
  • 6.5.3 Guanhao Biotech Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Guanhao Biotech Product Portfolio
  • 6.5.5 Guanhao Biotech Recent Developments/Updates
• 6.6 PermeaDerm
  • 6.6.1 PermeaDerm Corporation Information
  • 6.6.2 PermeaDerm Description and Business Overview
  • 6.6.3 PermeaDerm Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 PermeaDerm Product Portfolio
  • 6.6.5 PermeaDerm Recent Developments/Updates
• 6.7 Mylan (Viatris)
  • 6.6.1 Mylan (Viatris) Corporation Information
  • 6.6.2 Mylan (Viatris) Description and Business Overview
  • 6.6.3 Mylan (Viatris) Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Mylan (Viatris) Product Portfolio
  • 6.7.5 Mylan (Viatris) Recent Developments/Updates
• 6.8 MiMedx
  • 6.8.1 MiMedx Corporation Information
  • 6.8.2 MiMedx Description and Business Overview
  • 6.8.3 MiMedx Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 MiMedx Product Portfolio
  • 6.8.5 MiMedx Recent Developments/Updates
• 6.9 Tissue Regenix
  • 6.9.1 Tissue Regenix Corporation Information
  • 6.9.2 Tissue Regenix Description and Business Overview
  • 6.9.3 Tissue Regenix Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Tissue Regenix Product Portfolio
  • 6.9.5 Tissue Regenix Recent Developments/Updates
• 6.10 Allergan
  • 6.10.1 Allergan Corporation Information
  • 6.10.2 Allergan Description and Business Overview
  • 6.10.3 Allergan Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Allergan Product Portfolio
  • 6.10.5 Allergan Recent Developments/Updates

7 Dermal Substitutes Manufacturing Cost Analysis

• 7.1 Dermal Substitutes Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Dermal Substitutes
• 7.4 Dermal Substitutes Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Dermal Substitutes Distributors List
• 8.3 Dermal Substitutes Customers

9 Dermal Substitutes Market Dynamics

• 9.1 Dermal Substitutes Industry Trends
• 9.2 Dermal Substitutes Growth Drivers
• 9.3 Dermal Substitutes Market Challenges
• 9.4 Dermal Substitutes Market Restraints

10 Global Market Forecast

• 10.1 Dermal Substitutes Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Dermal Substitutes by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Dermal Substitutes by Type (2022-2027)
• 10.2 Dermal Substitutes Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Dermal Substitutes by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Dermal Substitutes by Application (2022-2027)
• 10.3 Dermal Substitutes Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Dermal Substitutes by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Dermal Substitutes by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List